ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $124,000 | -37.1% | 115,602 | 0.0% | 0.01% | -31.2% |
| Q2 2022 | $197,000 | -17.2% | 115,602 | 0.0% | 0.02% | +33.3% |
| Q1 2022 | $238,000 | -45.2% | 115,602 | 0.0% | 0.01% | -65.7% |
| Q4 2021 | $434,000 | -27.4% | 115,602 | 0.0% | 0.04% | -44.4% |
| Q3 2021 | $598,000 | +21.5% | 115,602 | 0.0% | 0.06% | +28.6% |
| Q2 2021 | $492,000 | -19.9% | 115,602 | 0.0% | 0.05% | -23.4% |
| Q1 2021 | $614,000 | -6.3% | 115,602 | -4.9% | 0.06% | -5.9% |
| Q4 2020 | $655,000 | -32.5% | 121,543 | 0.0% | 0.07% | -35.2% |
| Q3 2020 | $970,000 | -20.3% | 121,543 | 0.0% | 0.10% | -29.5% |
| Q2 2020 | $1,217,000 | +214.5% | 121,543 | -14.6% | 0.15% | +254.8% |
| Q1 2020 | $387,000 | +116.2% | 142,374 | -4.8% | 0.04% | +180.0% |
| Q4 2019 | $179,000 | -20.8% | 149,507 | 0.0% | 0.02% | -16.7% |
| Q3 2019 | $226,000 | -66.1% | 149,507 | -9.9% | 0.02% | -58.1% |
| Q2 2019 | $667,000 | -16.4% | 165,947 | -10.6% | 0.04% | -10.4% |
| Q1 2019 | $798,000 | -34.0% | 185,537 | -11.8% | 0.05% | -18.6% |
| Q4 2018 | $1,210,000 | -69.9% | 210,459 | -29.1% | 0.06% | -55.3% |
| Q3 2018 | $4,024,000 | +14.2% | 296,783 | 0.0% | 0.13% | +33.3% |
| Q2 2018 | $3,523,000 | – | 296,783 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |